IGF1 and cardiac hypertrophy: These results are consistent with the previous study that SIRT6 inhibit the transcription of IGF/Akt pathway genes via H3K9 deacetylation, which contributes to suppression of cardiac hypertrophy (Sundaresan et al., 2012).